Point of Care Testing Market Share will Touch US$ 38.40 Bn by 2026

0
8

Global Point of Care Testing Market Size is anticipated to grow at 7.4 % CAGR during the forecast period and reach around US$ 38.40 Billion by 2026.

Recent study titled, Point of Care Testing Market By Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 – 2026 which covers clear verifiable examination and lights up feature components and examples that give an extensive picture of the business.

The Point of Care Testing Market Industry Report is an in depth study analyzing the current state of the Point of Care Testing Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Point of Care Testing Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Point of Care Testing Market also discusses the opportunity areas for investors.

The study provides a decisive view of the market by segmenting it in terms of form and application. The segment has been analyzed based on present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1136

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

Market Participants:

Few of the significant contributor in the global point of care industry are Abaxis, Abbott, Siemens AG, F. Hoffmann-La Roche Ltd., and Johnson and Johnson.

The Major Market Segments of Global Point of Care Testing Market are as below:

Market Segmentation

Market By Product

  • Glucose monitoring
    • Strips
    • Meters
    • Lancets
  • Cardiometabolic testing products
    • Cardiac marker testing products
    • Blood Gas/Electrolytes testing products
    • HBA1C testing products
  • Infectious disease testing products
    • Influenza testing products
    • HIV testing products
    • Hepatitis C testing products
    • Sexually Transmitted Disease (STD) testing products
    • Healthcare-Associated Infection (HAI) testing products
    • Respiratory infection testing products
    • Tropical disease testing products
    • Other infectious diseases testing products
  • Coagulation testing products
    • PT/INR testing products
    • Activated Clotting Time (ACT/APTT) testing products
  • Pregnancy and fertility testing products
    • Pregnancy testing products
    • Fertility testing products
  • Tumor/Cancer marker testing products
  • Urinalysis testing products
  • Cholesterol testing products
  • Hematology testing products
  • Drug-of-Abuse (DoA) testing products
  • Fecal occult testing products
  • Other products

Market By Technology

  • Lateral flow assays
  • Dipsticks
  • Microfluidics
  • Molecular diagnostics
  • Immunoassays
  • Agglutination assays
  • Flow-Through
  • Solid phase
  • Biosensors

Market By Prescription

  • OTC testing
  • Prescription-based testing

Market By Application

  • Cardio metabolic testing
  • Infectious disease testing
  • Nephrology testing
  • Drug-of-Abuse (DoA) testing
  • Blood glucose testing
  • Pregnancy testing
  • Cancer biomarker testing
  • Other applications

Market By End-user

  • Hospitals
  • Diagnostic centers
  • Research laboratories
  • Home-care settings
  • Other end-uses

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

Germany overwhelmed the Europe POC testing market and was esteemed around USD 1,718.4 million in the year 2018. In the Federal Republic of Germany, purpose of-care frameworks are progressively utilized inside hospitals and medical practices. Other therapeutic offices where point of care testing is generally utilized incorporates outpatient nursing care, drug stores and home visits. Along these lines, developing reception of point of care testing the country over will drive the provincial market development.

Japan POC testing market is anticipated to develop at a CAGR of 8.7% over the projection time frame. According to the measurements distributed by the World Health Organization (WHO), in excess of 20,000 individuals were experiencing HIV and tuberculosis in Japan in the year 2016. This rising rate animates the demand for point of care testingdiagnostics tests bringing about developing demand and selection rate of point of care testing gadgets in the nation.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/point-of-care-testing-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Point of Care Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Point of Care Testing Market By Product
1.2.2.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Point of Care Testing Market Revenue Share By Product in 2017
1.2.2.3. Glucose monitoring
1.2.2.4. Cardiometabolic testing products
1.2.2.5. Infectious disease testing products
1.2.2.6. Coagulation testing products
1.2.2.7. Pregnancy and fertility testing products
1.2.2.8. Tumor/Cancer marker testing products
1.2.2.9. Urinalysis testing products
1.2.2.10. Cholesterol testing products
1.2.2.11. Hematology testing products
1.2.2.12. Drug-of-Abuse (DoA) testing products
1.2.2.13. Fecal occult testing products
1.2.2.14. Others
1.2.3. Point of Care Testing Market By Technology
1.2.3.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Point of Care Testing Market Revenue Share By Technology in 2017
1.2.3.3. Lateral flow assays
1.2.3.4. Dipsticks
1.2.3.5. Microfluidics
1.2.3.6. Molecular diagnostics
1.2.3.7. Immunoassays
1.2.3.8. Agglutination assays
1.2.3.9. Flow-Through
1.2.3.10. Solid phase
1.2.3.11. Biosensors
1.2.3.12. Others
1.2.4. Point of Care Testing Market By Prescription
1.2.4.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Prescription (2015-2026)
1.2.4.2. Global Point of Care Testing Market Revenue Share By Prescription in 2017
1.2.4.3. Otc Testing
1.2.4.4. Prescription-Based Testing
1.2.4.5. Others
1.2.5. Point of Care Testing Market By Application
1.2.5.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison BY APPLICATION (2015-2026)
1.2.5.2. Global Point of Care Testing Market Revenue Share BY APPLICATION in 2017
1.2.5.3. Cardio metabolic testing
1.2.5.4. Infectious disease testing
1.2.5.5. Nephrology testing
1.2.5.6. Drug-of-Abuse (DoA) testing
1.2.5.7. Blood glucose testing
1.2.5.8. Pregnancy testing
1.2.5.9. Cancer biomarker testing
1.2.5.10. Others
1.2.6. Point of Care Testing Market By End-user
1.2.6.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.6.2. Global Point of Care Testing Market Revenue Share By End-user in 2017
1.2.6.3. Hospitals
1.2.6.4. Diagnostic centers
1.2.6.5. Research laboratories
1.2.6.6. Home-care settings
1.2.6.7. Others
1.2.7. Point of Care Testing Market by Geography
1.2.7.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.7.2. North America Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.3. Europe Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.4. Asia-Pacific Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.5. Latin America Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.6. Middle East and Africa (MEA) Point of Care Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Cardio metabolic testing Production Date of Global Point of Care Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Point of Care Testing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Point of Care Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Point of Care Testing Major Manufacturers in 2017

CHAPTER 4. Point of Care Testing MARKET BY PRODUCT

4.1. Global Point of Care Testing Revenue By Product
4.2. Glucose monitoring
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Cardiometabolic testing products
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Infectious disease testing products
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Coagulation testing products
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Pregnancy and fertility testing products
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Tumor/Cancer marker testing products
4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.8. Urinalysis testing products
4.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.9. Cholesterol testing products
4.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.10. Hematology testing products
4.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.11. Drug-of-Abuse (DoA) testing products
4.11.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.12. Fecal occult testing products
4.12.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.12.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.13. Others
4.13.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.13.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. Point of Care Testing MARKET By Technology

5.1. Global Point of Care Testing Revenue By Technology
5.2. Lateral flow assays
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Dipsticks
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Microfluidics
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Molecular diagnostics
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Immunoassays
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.7. Agglutination assays
5.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.8. Flow-Through
5.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.9. Solid phase
5.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.10. Biosensors
5.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.11. Others
5.11.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.11.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. Point of Care Testing MARKET By Prescription

6.1. Global Point of Care Testing Revenue By Prescription
6.2. Otc Testing
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Prescription-Based Testing
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. Point of Care Testing MARKET BY APPLICATION

7.1. Global Point of Care Testing Revenue BY APPLICATION
7.2. Cardio metabolic testing
7.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.3. Infectious disease testing
7.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.4. Nephrology testing
7.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.5. Drug-of-Abuse (DoA) testing
7.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.6. Blood glucose testing
7.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.7. Pregnancy testing
7.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.8. Cancer biomarker testing
7.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
7.9. Others
7.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 8. Point of Care Testing MARKET By End-user

8.1. Global Point of Care Testing Revenue By End-user
8.2. Hospitals
8.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
8.3. Diagnostic centers
8.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
8.4. Research laboratories
8.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
8.5. Home-care settings
8.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
8.6. Others
8.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 9. NORTH AMERICA Point of Care Testing MARKET BY COUNTRY

9.1. North America Point of Care Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. North America Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. U.S.
9.3.1. U.S. Point of Care Testing Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.4. Canada
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
9.5. Mexico
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 10. EUROPE Point of Care Testing MARKET BY COUNTRY

10.1. Europe Point of Care Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Europe Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. UK
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.4. Germany
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.5. France
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.6. Spain
10.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
10.7. Rest of Europe
10.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 11. ASIA-PACIFIC Point of Care Testing MARKET BY COUNTRY

11.1. Asia-Pacific Point of Care Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Asia-Pacific Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. China
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.4. Japan
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.5. India
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.6. Australia
11.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.6.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.7. South Korea
11.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.7.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
11.8. Rest of Asia-Pacific
11.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.8.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 12. LATIN AMERICA Point of Care Testing MARKET BY COUNTRY

12.1. Latin America Point of Care Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Latin America Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. Brazil
12.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.4. Argentina
12.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
12.5. Rest of Latin America
12.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 13. MIDDLE EAST Point of Care Testing MARKET BY COUNTRY

13.1. Middle East Point of Care Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
13.2. Middle East Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
13.3. Saudi Arabia
13.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
13.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
13.4. UAE
13.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
13.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
13.5. Rest of Middle East
13.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
13.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 14. AFRICA Point of Care Testing MARKET BY COUNTRY

14.1. Africa Point of Care Testing Market Revenue and Growth Rate, 2015 – 2026 ($Million)
14.2. Africa Point of Care Testing Market Revenue Share Comparison, 2015 & 2026 (%)
14.3. South Africa
14.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
14.3.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
14.4. Egypt
14.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
14.4.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
14.5. Rest of Africa
14.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
14.5.2. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)

CHAPTER 15. COMPANY PROFILE

15.1. Abaxis
15.1.1. Company Snapshot
15.1.2. Overview
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Key Developments
15.1.6. Strategies
15.2. Abbott
15.2.1. Company Snapshot
15.2.2. Overview
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Key Developments
15.2.6. Strategies
15.3. Siemens AG
15.3.1. Company Snapshot
15.3.2. Overview
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Key Developments
15.3.6. Strategies
15.4. F. Hoffmann-La Roche Ltd.
15.4.1. Company Snapshot
15.4.2. Overview
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Key Developments
15.4.6. Strategies
15.5. Johnson and Johnson
15.5.1. Company Snapshot
15.5.2. Overview
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Key Developments
15.5.6. Strategies
15.6. Others
15.6.1. Company Snapshot
15.6.2. Overview
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Key Developments
15.6.6. Strategies

CHAPTER 16. RESEARCH APPROACH

16.1. Research Methodology
16.1.1. Initial Data Search
16.1.2. Secondary Research
16.1.3. Primary Research
16.2. Assumptions and Scope

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1136

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

SHARE
Sonia Mehta is a writer from Delhi, India, looking to break into the freelance copywriting field. Sonia covers health and lifestyle news as well as medical research news from around the world.

LEAVE A REPLY

Please enter your comment!
Please enter your name here